Results of Study on COVID-19 Vaccine Response in Hematopoietic Cell Transplant Patients Published in eClinicalMedicine
24 mai 2023 11h28 HE
|
Be The Match
MINNEAPOLIS, May 24, 2023 (GLOBE NEWSWIRE) -- Results from a joint study between CIBMTR® (Center for International Blood and Marrow Transplant Research®)—a research collaboration between the...
AIM ImmunoTech Reports First Quarter Financial Results and Provides Pipeline Update
15 mai 2023 08h45 HE
|
AIM ImmunoTech Inc.
– Continued execution across pipeline positions AIM to achieve multiple clinical and regulatory value-driving milestones throughout 2023– Lead clinical program, Phase 2 locally advance pancreatic...
Kinarus Therapeutics signed CHF1.5 million convertible loan agreement with ChaoDian (Hangzhou) Investment Management
11 mai 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Basel, Switzerland, May 10, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage biopharmaceutical company developing novel therapeutics to treat viral, respiratory and...
Kinarus Therapeutics Reports Key Unaudited Full Year 2022 Figures
05 mai 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Audited full year 2022 annual financial figures due to be reported by end of May 2023 Basel, Switzerland, May 5, 2023 – Kinarus Therapeutics Holding AG (“Kinarus”) (SIX: KNRS), a clinical-stage...
International Covid Memorial Monument Design Competition Underway
02 mai 2023 11h57 HE
|
The Hektoen Institute COVID-19 Monument Commission
CHICAGO, May 02, 2023 (GLOBE NEWSWIRE) -- An international design competition is underway for a Covid memorial monument. The winning design will be awarded $20,000 USD. A distinguished panel of...
Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report
28 avr. 2023 01h00 HE
|
Kinarus Therapeutic Holding AG
Ad hoc announcement pursuant to Art. 53 LR Kinarus Therapeutics Holding AG ("Kinarus") receives deadline extension from SER for publication of its 2022 annual financial report Basel, Switzerland, 28...
Philips and MIT IMES develop enhanced critical care data set to give researchers and educators access to advance clinical understanding and AI in healthcare
18 avr. 2023 10h00 HE
|
Royal Philips
April 18, 2023 Latest clinical data set of 200,000 patients from over 200 hospitals, includes pandemic data for a broader and dependable foundation for machine learning Amsterdam, the Netherlands...
GeoVax Announces Expansion of Next-Generation COVID-19 Vaccine Rights to Include Omicron Variants and Use Against Orthopoxviruses
17 avr. 2023 09h00 HE
|
GeoVax, Inc.
Expanded Rights Include Development of GEO-CM04S1 Against Mpox (Monkeypox) and Smallpox ATLANTA, GA, April 17, 2023 (GLOBE NEWSWIRE) -- via NewMediaWire -- GeoVax Labs, Inc. (Nasdaq: GOVX), a...
Blood Testing Market to Reach USD 218.2 Bn by 2032 Growing at a 9.6% CAGR | TMR Study
14 avr. 2023 12h30 HE
|
Transparency Market Research
Wilmington, Delaware, United States, April 14, 2023 (GLOBE NEWSWIRE) -- The blood testing market was valued at USD 80.2 Bn in 2021 and the global market is anticipated to reach USD 218.2 Bn....
AIM ImmunoTech Appoints Preeminent Biotechnology Pioneer, W. Neal Burnette, Ph.D., as Chairman of its Scientific Advisory Board (SAB)
12 avr. 2023 08h35 HE
|
AIM ImmunoTech Inc.
Company’s SAB is comprised of well-established leaders with expertise across biomedical research, academia, and pharmaceutical industry OCALA, Fla., April 12, 2023 (GLOBE NEWSWIRE) -- AIM...